Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study

BACKGROUND: Patients with diabetic kidney disease (DKD) are at increased risk to develop post-contrast acute kidney injury (AKI). Diabetic patients under dipeptidyl peptidase 4 inhibitors (DPP4Is) experience a lower propensity to develop AKI. We speculated that linagliptin as a single agent or in co...

Descripción completa

Detalles Bibliográficos
Autores principales: Fayed, Ahmed, Hammad, Ahmed A., Abdulazim, Dina O., Hammad, Hany, Amin, Mohamed, Elhadidy, Samir, Salem, Mona M., ElAzim, Ibrahim M. Abd, Zsom, Lajos, Csongradi, Eva, Soliman, Karim M., Sharaf El Din, Usama A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054158/
https://www.ncbi.nlm.nih.gov/pubmed/36974638
http://dx.doi.org/10.1080/0886022X.2023.2194434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054158/
https://www.ncbi.nlm.nih.gov/pubmed/36974638
http://dx.doi.org/10.1080/0886022X.2023.2194434

Ejemplares similares